 On track to fulfill all elements of Vision 3×3 to build a sustainable, profitable, leading biopharma company COPENHAGEN, Denmark, Jan. 08, 2023 GLOBE NEWSWIRE Ascendis Pharma AS Nasdaq: ASND today provided an update on its Vision 3×3 strategic roadmap and planned 2023 key corporate milestones. Ascendis President and CEO Jan Mikkelsen will present ... The post Ascendis Pharma Provides Update on Vision 3×3 Strategic Roadmap at 41st Annual J.P. Morgan Healthcare Conference appeared first... 